Client Technology. Client hereby grants to Catalent a non-exclusive, fully paid-up and royalty-free license, with the right to sublicense to Catalent’s Affiliates, under any and all technology owned by or licensed to Client with respect to the Drug or any formulations of the Drug for the sole purpose of carrying out Catalent’s obligations under this Agreement, the Development Program and any Supply Agreement.
Appears in 4 contracts
Samples: Zydis Development and License Agreement, Zydis Development and License Agreement (Biohaven Pharmaceutical Holding Co Ltd.), Zydis Development and License Agreement (Biohaven Pharmaceutical Holding Co Ltd.)
